Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 2.280
-0.010 (-0.44%)
Jun 18, 2026, 1:53 PM HKT
Kintor Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -200.11 | -155.29 | -1,061 | -954.37 | -842.1 |
Depreciation & Amortization | 33.11 | 17.49 | 18.86 | 18.24 | 10.37 |
Other Amortization | 0.1 | 0.13 | 0.12 | 0.15 | 0.14 |
Loss (Gain) From Sale of Assets | 0.06 | -2.52 | -0.01 | 0.62 | 0.11 |
Asset Writedown & Restructuring Costs | 27.13 | 13.82 | 134.07 | - | - |
Loss (Gain) From Sale of Investments | - | -0 | -0.49 | -2 | -0.78 |
Loss (Gain) on Equity Investments | -0.77 | 1.43 | -0.05 | 0.57 | - |
Stock-Based Compensation | 0.32 | -9.11 | 22.99 | 95.64 | 37.35 |
Provision & Write-off of Bad Debts | -0.9 | 1.21 | - | - | - |
Other Operating Activities | -5.79 | -15.1 | 594.24 | 77.85 | 28.13 |
Change in Accounts Receivable | -0.34 | 8.57 | 7.62 | 94.23 | -86.03 |
Change in Inventory | -9.62 | -4.32 | -0.38 | -345.13 | -351.36 |
Change in Accounts Payable | -11.3 | -49.95 | -106.84 | 6.76 | 155.32 |
Change in Unearned Revenue | 0.44 | - | -0.3 | 15.94 | 3.65 |
Change in Other Net Operating Assets | -2.07 | -5.44 | 3.41 | 30.24 | -6.16 |
Operating Cash Flow | -169.74 | -199.08 | -387.58 | -961.26 | -1,051 |
Capital Expenditures | -0.74 | -1.54 | -2.72 | -27.47 | -76.24 |
Sale of Property, Plant & Equipment | 0.02 | 0.23 | 0.21 | 0.2 | 0.01 |
Sale (Purchase) of Intangibles | 15.65 | 10.29 | - | -0.18 | -29.5 |
Investment in Securities | 1.08 | 10 | -0.85 | 97.84 | 195.53 |
Other Investing Activities | -1.6 | 1.05 | 6.64 | -3.19 | 2.2 |
Investing Cash Flow | 14.41 | 20.03 | 3.27 | 67.2 | 92.01 |
Long-Term Debt Issued | 116.39 | 34.28 | 70 | 170 | 20 |
Long-Term Debt Repaid | -164.42 | -154.33 | -104.22 | -53.01 | -112.52 |
Net Debt Issued (Repaid) | -48.03 | -120.04 | -34.22 | 116.99 | -92.52 |
Issuance of Common Stock | 88.3 | 0.37 | 0.76 | 698.76 | 951.97 |
Other Financing Activities | - | - | - | - | -2.03 |
Financing Cash Flow | 40.27 | -119.67 | -33.46 | 815.75 | 857.42 |
Foreign Exchange Rate Adjustments | 0.38 | 2.11 | -2.67 | 16.45 | -36.42 |
Net Cash Flow | -114.68 | -296.61 | -420.44 | -61.86 | -138.36 |
Free Cash Flow | -170.48 | -200.62 | -390.3 | -988.73 | -1,128 |
Free Cash Flow Margin | -521.63% | -4012.36% | - | - | -3294.09% |
Free Cash Flow Per Share | -0.38 | -0.47 | -0.91 | -2.63 | -3.16 |
Cash Interest Paid | 3.94 | 9.29 | 12.12 | 9.96 | 6.77 |
Cash Income Tax Paid | 1.51 | 0.02 | 0.29 | 0.91 | 0.81 |
Levered Free Cash Flow | -71.77 | -139.78 | -36.72 | -681.67 | -895.55 |
Unlevered Free Cash Flow | -69.31 | -133.99 | -30.66 | -676.55 | -893.99 |
Change in Working Capital | -22.9 | -51.14 | -96.48 | -197.95 | -284.59 |